Tech Company Financing Transactions

Iron Horse Therapeutics Funding Round

Iron Horse Therapeutics, operating out of Scottsdale, secured $10 million from Avalon Ventures, GlaxoSmithKline and private investors.

Transaction Overview

Announced On
11/10/2015
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
21053 N 75th St.
Scottsdale, AZ 85255
USA
Website
Email Address
Not Recorded
Overview
Iron Horse Diagnostics was formed by Dr. Robert Bowser, an internationally renowned research scientist, to create breakthrough diagnostic tests in neurologic disorders with high-unmet medical need.
Profile
Iron Horse Therapeutics LinkedIn Company Profile
Social Media
Iron Horse Therapeutics Company Twitter Account
Company News
Iron Horse Therapeutics News
Facebook
Iron Horse Therapeutics on Facebook
YouTube
Iron Horse Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Bowser
  Robert Bowser LinkedIn Profile  Robert Bowser Twitter Account  Robert Bowser News  Robert Bowser on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/10/2015: MiRagen Therapeutics venture capital transaction
Next: 11/10/2015: Shelfbucks venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary